Balkhy Husam H, Grossi Eugene A, Kiaii Bob, Murphy Shannon M E, Kitahara Hiroto, Guy T Sloane, Lewis Clifton
University of Chicago Medicine, IL, USA.
New York University Langone Health, NY, USA.
Innovations (Phila). 2023 Jul-Aug;18(4):338-345. doi: 10.1177/15569845231185311. Epub 2023 Jul 17.
Endoaortic balloon occlusion facilitates cardioplegic arrest during minimally invasive surgery (MIS). Studies have shown endoclamping to be as safe as traditional aortic clamping. We compared outcomes and hospital costs of endoclamping versus external aortic occlusion in a large administrative database.
There were 52,882 adults undergoing eligible cardiac surgery (October 2015 to March 2020) identified in the Premier Healthcare Database. Endoclamp procedures ( = 419) were 1:3 propensity score matched to similar procedures using external aortic occlusion ( = 1,244). Generalized linear modeling measured differences in in-hospital complications (major adverse renal and cardiac events, including mortality, new-onset atrial fibrillation, acute kidney injury [AKI], myocardial infarction [MI], postcardiotomy syndrome, stroke/transient ischemic attack [TIA], and aortic dissection) and length of stay (LOS).
The mean age was 63 years, and 53% were male ( = 882). The majority (93%, = 1,543) were mitral valve procedures, and 17% of procedures ( = 285) were robot-assisted. Total hospitalization costs were not statistically significantly different between the 2 groups ($52,158 vs $49,839, = 0.06). The median LOS was significantly shorter in the endoclamp group (incident rate ratio = 0.87, < 0.001). Mortality, atrial fibrillation, AKI, and stroke/TIA were similar between the 2 groups. MI and postcardiotomy syndrome were lower in the endoclamp group (odds ratio [OR] = 0.14, = 0.006, and OR = 0.27, = 0.005). There were no aortic dissections in the endoclamp group.
Aortic endoclamping in MIS was associated with similar costs, shorter LOS, no dissections, and comparably low mortality and stroke rates when compared with external clamping in this hospital billing dataset. These results demonstrate the clinical safety and efficacy of endoaortic balloon clamping in a real-world setting. Further studies are warranted.
主动脉内球囊阻断有助于在微创手术(MIS)期间实施心脏停搏。研究表明,腔内钳夹与传统主动脉钳夹一样安全。我们在一个大型管理数据库中比较了腔内钳夹与体外主动脉阻断的结果和住院费用。
在Premier医疗数据库中识别出52882例接受符合条件心脏手术的成年人(2015年10月至2020年3月)。腔内钳夹手术(n = 419)与采用体外主动脉阻断的类似手术(n = 1244)按1:3倾向评分匹配。广义线性模型测量住院并发症(主要不良肾脏和心脏事件,包括死亡率、新发房颤、急性肾损伤[AKI]、心肌梗死[MI]、心脏切开术后综合征、中风/短暂性脑缺血发作[TIA]和主动脉夹层)和住院时间(LOS)的差异。
平均年龄为63岁,53%为男性(n = 882)。大多数(93%,n = 1543)为二尖瓣手术,17%的手术(n = 285)为机器人辅助手术。两组的总住院费用无统计学显著差异(52158美元对49839美元,P = 0.06)。腔内钳夹组的中位LOS显著更短(发生率比 = 0.87,P < 0.001)。两组的死亡率、房颤、AKI和中风/TIA相似。腔内钳夹组的MI和心脏切开术后综合征较低(优势比[OR] = 0.14,P = 0.006,OR = 0.27,P = 0.005)。腔内钳夹组无主动脉夹层。
在此医院计费数据集中,与体外钳夹相比,MIS中的主动脉腔内钳夹具有相似的费用、更短的LOS、无夹层以及相当低的死亡率和中风率。这些结果证明了主动脉内球囊钳夹在实际临床中的安全性和有效性。有必要进行进一步研究。